Literature DB >> 22749012

Pluripotent stem cells models for Huntington's disease: prospects and challenges.

Richard L Carter1, Anthony W S Chan.   

Abstract

Pluripotent cellular models have shown great promise in the study of a number of neurological disorders. Several advantages of using a stem cell model include the potential for cells to derive disease relevant neuronal cell types, providing a system for researchers to monitor disease progression during neurogenesis, along with serving as a platform for drug discovery. A number of stem cell derived models have been employed to establish in vitro research models of Huntington's disease that can be used to investigate cellular pathology and screen for drug and cell-based therapies. Although some progress has been made, there are a number of challenges and limitations that must be overcome before the true potential of this research strategy is achieved. In this article we review current stem cell models that have been reported, as well as discuss the issues that impair these studies. We also highlight the prospective application of Huntington's disease stem cell models in the development of novel therapeutic strategies and advancement of personalized medicine.
Copyright © 2012. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22749012      PMCID: PMC4075320          DOI: 10.1016/j.jgg.2012.04.006

Source DB:  PubMed          Journal:  J Genet Genomics        ISSN: 1673-8527            Impact factor:   4.275


  77 in total

1.  Derivation of Huntington's disease-affected human embryonic stem cell lines.

Authors:  Cara K Bradley; Heather A Scott; Omar Chami; Teija T Peura; Biljana Dumevska; Uli Schmidt; Tomas Stojanov
Journal:  Stem Cells Dev       Date:  2010-08-31       Impact factor: 3.272

2.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

Review 3.  Induced pluripotent stem cells (iPSCs) and neurological disease modeling: progress and promises.

Authors:  Maria C Marchetto; Kristen J Brennand; Leah F Boyer; Fred H Gage
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

Review 4.  Stem cell technology for neurodegenerative diseases.

Authors:  J Simon Lunn; Stacey A Sakowski; Junguk Hur; Eva L Feldman
Journal:  Ann Neurol       Date:  2011-09       Impact factor: 10.422

Review 5.  Technical challenges in using human induced pluripotent stem cells to model disease.

Authors:  Krishanu Saha; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2009-12-04       Impact factor: 24.633

6.  Characterization of Human Huntington's Disease Cell Model from Induced Pluripotent Stem Cells.

Authors:  Ningzhe Zhang; Mahru C An; Daniel Montoro; Lisa M Ellerby
Journal:  PLoS Curr       Date:  2010-10-28

7.  Putative dental pulp-derived stem/stromal cells promote proliferation and differentiation of endogenous neural cells in the hippocampus of mice.

Authors:  Anderson Hsien-Cheng Huang; Brooke R Snyder; Pei-Hsun Cheng; Anthony W S Chan
Journal:  Stem Cells       Date:  2008-08-07       Impact factor: 6.277

8.  Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice.

Authors:  Ryan L Boudreau; Jodi L McBride; Inês Martins; Shihao Shen; Yi Xing; Barrie J Carter; Beverly L Davidson
Journal:  Mol Ther       Date:  2009-02-24       Impact factor: 11.454

9.  Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse models.

Authors:  Liliana Menalled; Bassem F El-Khodor; Monica Patry; Mayte Suárez-Fariñas; Samantha J Orenstein; Benjamin Zahasky; Christina Leahy; Vanessa Wheeler; X William Yang; Marcy MacDonald; A Jennifer Morton; Gill Bates; Janet Leeds; Larry Park; David Howland; Ethan Signer; Allan Tobin; Daniela Brunner
Journal:  Neurobiol Dis       Date:  2009-05-21       Impact factor: 5.996

10.  CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo.

Authors:  Victor M Miller; Rick F Nelson; Cynthia M Gouvion; Aislinn Williams; Edgardo Rodriguez-Lebron; Scott Q Harper; Beverly L Davidson; Michael R Rebagliati; Henry L Paulson
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.709

View more
  9 in total

Review 1.  Progress and prospects for genetic modification of nonhuman primate models in biomedical research.

Authors:  Anthony W S Chan
Journal:  ILAR J       Date:  2013

Review 2.  Genetic engineered molecular imaging probes for applications in cell therapy: emphasis on MRI approach.

Authors:  In K Cho; Silun Wang; Hui Mao; Anthony Ws Chan
Journal:  Am J Nucl Med Mol Imaging       Date:  2016-09-22

Review 3.  Generation of genetically engineered non-human primate models of brain function and neurological disorders.

Authors:  Jung Eun Park; Afonso C Silva
Journal:  Am J Primatol       Date:  2018-12-26       Impact factor: 2.371

Review 4.  Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics.

Authors:  Neha Sawant; Hallie Morton; Sudhir Kshirsagar; Arubala P Reddy; P Hemachandra Reddy
Journal:  Mol Neurobiol       Date:  2021-09-14       Impact factor: 5.590

5.  Pathogenic cellular phenotypes are germline transmissible in a transgenic primate model of Huntington's disease.

Authors:  Kittiphong Putkhao; Jannet Kocerha; In-Ki Cho; Jinjing Yang; Rangsun Parnpai; Anthony W S Chan
Journal:  Stem Cells Dev       Date:  2013-01-15       Impact factor: 3.272

Review 6.  Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases.

Authors:  Shripriya Singh; Akriti Srivastava; Pranay Srivastava; Yogesh K Dhuriya; Ankita Pandey; Dipak Kumar; Chetan S Rajpurohit
Journal:  Front Mol Biosci       Date:  2016-11-08

7.  Functions of huntingtin in germ layer specification and organogenesis.

Authors:  Giang D Nguyen; Aldrin E Molero; Solen Gokhan; Mark F Mehler
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

Review 8.  Recent Overview of the Use of iPSCs Huntington's Disease Modeling and Therapy.

Authors:  Maria Csobonyeiova; Stefan Polak; Lubos Danisovic
Journal:  Int J Mol Sci       Date:  2020-03-24       Impact factor: 5.923

9.  A functional hiPSC-cortical neuron differentiation and maturation model and its application to neurological disorders.

Authors:  Kaveena Autar; Xiufang Guo; John W Rumsey; Christopher J Long; Nesar Akanda; Max Jackson; Narasimhan S Narasimhan; Julbert Caneus; Dave Morgan; James J Hickman
Journal:  Stem Cell Reports       Date:  2021-12-22       Impact factor: 7.294

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.